Your browser doesn't support javascript.
loading
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome.
Pecher, Ann-Christin; Hensen, Luca; Klein, Reinhild; Schairer, Rebekka; Lutz, Katrin; Atar, Daniel; Seitz, Christian; Stanger, Anna; Schneider, Janine; Braun, Christiane; Schmidt, Marina; Horger, Marius; Bornemann, Antje; Faul, Christoph; Bethge, Wolfgang; Henes, Joerg; Lengerke, Claudia.
Afiliación
  • Pecher AC; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Hensen L; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Klein R; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Schairer R; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Lutz K; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Atar D; Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital Tübingen, Tübingen, Germany.
  • Seitz C; Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital Tübingen, Tübingen, Germany.
  • Stanger A; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Schneider J; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Braun C; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Schmidt M; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Horger M; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.
  • Bornemann A; Department of Pathology and Neuropathology and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.
  • Faul C; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Bethge W; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Henes J; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Lengerke C; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
JAMA ; 329(24): 2154-2162, 2023 06 27.
Article en En | MEDLINE | ID: mdl-37367976

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Enfermedades Pulmonares Intersticiales / Antígenos CD19 / Receptores Quiméricos de Antígenos / Miositis Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Enfermedades Pulmonares Intersticiales / Antígenos CD19 / Receptores Quiméricos de Antígenos / Miositis Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article